CD30+ cutaneous T-cell lymphoma
MeSH: D054446ORPHA: 3008651 Treatment Available
Overview
anaplastic lymphoma of the skin which develops as a primary neoplasm expressing the CD30 antigen
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Brentuximab vedotin Orphan Cold Chain | Intravenous injection | FDA Approved | 6 | 7d |
Classification & Codes
MeSH Code
D054446Orphanet Code
ORPHA:300865CD30+ cutaneous T-cell lymphoma
| MeSH | D054446 |
| Orphanet | ORPHA:300865 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO